Immunome to Present at the Goldman Sachs 47th Annual Global Healthcare Conference Life Science Investing
HCW Biologics Exercised Option to Regain Full Rights for Two Commercial-Ready Reagents from Wugen Life Science Investing
Palvella Therapeutics Strengthens QTORIN Pitavastatin Intellectual Property with Yale-Licensed U.S. Patent Providing Protection into 2043 Life Science Investing
Arrowhead Pharmaceuticals Presents New Clinical Data on RNAi-based Obesity and MASH Candidate ARO-INHBE at EASL 2026 Life Science Investing
Kymera Therapeutics to Participate in Fireside Chat at the Jefferies Global Healthcare Conference Life Science Investing
NRx Pharmaceuticals Subsidiary HOPE Therapeutics Becomes First Commercial Site to Deploy Zeta Surgical's FDA-Cleared Zeta TMS Navigation System Life Science Investing
Atea Pharmaceuticals Presents New Drug-Drug Interaction Results Supporting Potential Best-in-Class Profile of the Regimen of Bemnifosbuvir and Ruzasvir for the Treatment of Hepatitis C Virus at EASL Congress 2026 Life Science Investing
Immunic Appoints Distinguished Biopharmaceutical Executive Erik Lundgren as Chief Executive Officer Life Science Investing
BriaCell Receives Positive Recommendation from Data Safety Monitoring Board for Phase 3 Study in Metastatic Breast Cancer
